The potency of amphetamine’s isomers as monoamine reuptake inhibitors is summarised in Desk 2 and they are in contrast in opposition to some very powerful classical reuptake inhibitors. d-isomer, medical trials conducted from the 1970s demonstrated that the two isomers of amphetamine were being clinically efficient in treating ADHD (Arnold et al.